Ever since Akkermansia muciniphila was discovered and characterized two decades ago,
numerous studies have shown that the lack or decreased abundance of this commensal …

The gut microbiota plays a critical role in the modulation of host metabolism and immune
response, and its impairment has been implicated in many gastrointestinal and …

Background Akkermansia muciniphila is a human gut microbe with a key role in the
physiology of the intestinal mucus layer and reported associations with decreased body …

Akkermansia muciniphila, as a member of the gut microbiota, has been proposed as a next-
generation probiotic. Liver fibrosis is the main determinant of liver dysfunction and mortality …

Background Vascular calcification is a major cause of the high morbidity and mortality of
cardiovascular diseases and is closely associated with the intestinal microbiota. Short-chain …

Obesity is a complex syndrome and is recognized as the ultimate pathway of many chronic
diseases. Studies using Akkermansia muciniphila supplementation strategy have proved to …

The prevalence of type 2 diabetes (T2D) is increasing worldwide, with many patients
developing long-term complications that affect their cardiovascular, urinary, alimentary, and …

Obesity, a chronic metabolic disorder caused by an energy imbalance, has been
increasingly prevalent and poses a global health concern. The multifactorial etiology of …

A dysbiotic intestinal microbiome has been linked to chronic diseases such as obesity,
which may suggest that interventions that target the microbiome may be useful in treating …

Recently, Akkermansia muciniphila an anaerobic member of the gut microbiota, has been
proposed as a next-generation probiotic. The aim of this study was evaluation of the effect of …